Showing 1261-1270 of 6040 results for "".
Exploring the Complexities of Psoriasis
https://practicaldermatology.com/topics/psoriasis/exploring-the-complexities-of-psoriasis/18553/Biologic therapies developed over the last decade or more to treat psoriasis may do more than clear the skin. Researchers are investigating the effects of treatment on comorbid risks, and comparing treatment with older interventions. Jashin Wu, MD explains.Pico Pick-up: Expanding Applications
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/pico-pick-up-expanding-applications/18555/What started as a revolutionary approach to removing tattoos, is finding new applications for facial rejuvenation. The expanding use of picosecond technology is making the investment more attractive for aesthetically-focused practices, notes Dr. Gold.Differin Goes OTC, ISDIN Comes to America, Understand AD
https://practicaldermatology.com/topics/psoriasis/dermwiretv-differin-goes-otc-isdin-comes-to-america-understand-ad/18762/Barcelona-based ISDIN is officially operating in the US. The company—which operates in Europe, Latin America, and Asia—is bringing its skincare products to the US market. Regeneron Pharmaceuticals, Sanofi Genzyme, the National Eczema Association, and the Dermatology Nurses Association launch UnderBuilding Your Brand with Google+
https://practicaldermatology.com/topics/practice-management/building-your-brand-with-google-/18612/Google+ can be an important marketing tool for practices. It helps produce faster crawling and indexing of web pages and faster link equity. Learn more about how this tool can help practices grow and get tips on optimizing your use of this social platform.Systemic Implications of Psoriasis
https://practicaldermatology.com/topics/psoriasis/systemic-implications-of-psoriasis/18636/Although a disease with a presentation on the skin, psoriasis has important implications for systemic health. Joel Gelfand, MD, talks about the increased risk for diabetes and cardiovascular disease in patients with psoriasis, as well as the clinician's role in educating patients about their diseaseJUVEDERM Voluma Mid-Cheek Injection Demo Video
https://practicaldermatology.com/topics/general-topics/juvederm-voluma-mid-cheek-injection-demo-video/18872/Watch Dr Sheila Barbarino perform a pain free cheek injection using Juvederm Voluma at her Hermosa Beach plastic surgery center, Barbarino Surgical Arts. Juvederm Voluma is the latest of the Juvederm range of hyaluronic acid fillers specifically designed to restore volume in areas of volume loss. VoASDS BCC Recommendations; Bad Online Reviews for Derms
https://practicaldermatology.com/topics/practice-management/dermwiretv-asds-bcc-recommendations-bad-online-reviews-for-derms/18906/This edition of DermWireTV, from the editors of Practical Dermatology® magazine reviews the new ASDS Consensus Recommendation for the management of Basal Cell Carcinoma (BCC). An expert panel found Mohs micrographic surgery is highly cost effective. In other news, researchers find that dermatologist2014 Year in Review: Skin Cancer
https://practicaldermatology.com/topics/skin-cancer-photoprotection/2014-year-in-review-skin-cancer/19001/Gary Goldenberg, MD offers a snapshot look at the newest therapies in the skin cancer treatment landscape, as well as the newest innovations across various disease states in the specialty.Allergan Strikes $66 Billion Deal with Actavis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-allergan-strikes-66-billion-deal-with-actavis/19021/In this edition of DermWireTV, host Ranna Jaraha discusses this week's blockbuster merger deal between Allergan and Actavis. Also featured in this edition is a new report detailing the rising costs of treating skin cancer, and high recognition for a dermatologic device manufacturer.Understanding Sublative Therapy
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/understanding-sublative-therapy/19056/What is sublative? Michael H. Gold, MD explains how the technology works and how it fits in practice.